EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels

Chiara Colombo, Gabriele Tinè, Elena Palassini, Antonino Belfiore, Andrea Marrari, Paola Collini, Marco Fiore, Stefano Radaelli, Federica Perrone, Alba Miceli, Alessandro Gronchi

European Journal of Cancer · 2026-05 · 239 · 116673

DOI: 10.1016/j.ejca.2026.116673 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2026-05. Verfasst von Chiara Colombo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: chiara.colombo@istitutotumori.mi.it. Hauptthemen laut MEDLINE: Desmoid Tumors, Toremifene. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desmoid TumorsToremifeneAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultDose-Response Relationship, DrugProgression-Free SurvivalProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Desmoid-type fibromatosisPhase II studySporadicToremifene

Substanzen

Toremifene

Autor:innen und Institutionen

  • Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: chiara.colombo@istitutotumori.mi.it.
  • Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Colombo, C., Tinè, G., Palassini, E., Belfiore, A., Marrari, A., Collini, P., Fiore, M., Radaelli, S., Perrone, F., Miceli, A., & Gronchi, A. (2026). Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels. European Journal of Cancer, 239, 116673. https://doi.org/10.1016/j.ejca.2026.116673

Vancouver

Colombo C, Tinè G, Palassini E, Belfiore A, Marrari A, Collini P, et al. Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels. European Journal of Cancer. 2026;239:116673. doi:10.1016/j.ejca.2026.116673

BibTeX
@article{Colombo2026,
  author = {Colombo, Chiara and Tinè, Gabriele and Palassini, Elena and Belfiore, Antonino and Marrari, Andrea and Collini, Paola and Fiore, Marco and Radaelli, Stefano and Perrone, Federica and Miceli, Alba and Gronchi, Alessandro},
  title = {Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {239},
  pages = {116673},
  doi = {10.1016/j.ejca.2026.116673}
}
Kostenlos starten →